Skip to main content

Workflow in the multidisciplinary management of glioma patients in everyday practice: how we do it

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

Data availability

Not applicable.

Materials availability

Not applicable.

References

  1. Hsu CC, Watkins TW, Kwan GN, Haacke EM (2016) Susceptibility-weighted Imaging of glioma: update on current imaging status and future directions. J Neuroimaging. https://doi.org/10.1111/jon.12360

    Article  PubMed  Google Scholar 

  2. Boxerman JL, Shiroishi MS, Ellingson BMand Pope WB, (2016) Dynamic susceptibility contrast MR imaging in glioma: review of current clinical practice. Magn Reson Imaging Clin N Am. https://doi.org/10.1016/j.mric.2016.06.005

    Article  PubMed  Google Scholar 

  3. Danieli L, Riccitelli GC, Distefano D, Prodi E, Ventura E, Cianfoni A, Kaelin-Lang A, Reinert M, Pravatà E (2019) Brain tumor-enhancement visualization and morphometric assessment: a comparison of mprage, space, and vibe MRI techniques. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A6096

    Article  PubMed  PubMed Central  Google Scholar 

  4. From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO), Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA, Shazam Hussain M, Jansen O, Jayaraman MV, Khalessi AA, Kluck BW, Lavine S, Meyers PM, Ramee S, Rüfenacht DA, Schirmer CM, Vorwerk D, Multisociety (2018) Consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. https://doi.org/10.1177/1747493018778713

    Article  Google Scholar 

  5. Bisdas S, Schäfer R, Kolb R, Bender B, Klose U (2020) Lactate as clinical tumour biomarker: optimization of lactate detection and quantification in MR spectroscopic imaging of glioblastomas. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2020.109171

    Article  PubMed  Google Scholar 

  6. Inoue A, Nishikawa M, Ohnishi T, Yano H, Kanemura Y, Ohtsuka Y, Ozaki S, Nakamura Y, Matsumoto S, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T (2021) Prediction of glioma stemlike cell infiltration in the non-contrast-enhancing area by quantitative measurement of lactate on magnetic resonance spectroscopy in glioblastoma. World Neurosurg. https://doi.org/10.1016/j.wneu.2021.06.044

    Article  PubMed  Google Scholar 

  7. Jiang H, Cui Y, Liu X, Ren X, Li Mand Lin S (2019) Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region. J Neurosurg. https://doi.org/10.3171/2018.12.JNS182775

    Article  PubMed  Google Scholar 

  8. Mrowczynski OD, Zammar S, Bourcier AJ, Langan ST, Liao J, Specht CS, Rizk EB (2018) Utility of early postoperative magnetic resonance imaging after glioblastoma resection: implications on patient survival. World Neurosurg. https://doi.org/10.1016/j.wneu.2018.09.027

    Article  PubMed  Google Scholar 

  9. Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response assessment in neuro-oncology working group and European Association for Neuro-oncology Recommendations for the clinical use of pet imaging in gliomas. Neuro Oncol. https://doi.org/10.1093/neuonc/now058

    Article  PubMed  PubMed Central  Google Scholar 

  10. de Zwart PL, van Dijken BRJ, Holtman GA, Stormezand GN, Dierckx RAJO, Jan van Laar P, van der Hoorn A (2020) Diagnostic accuracy of pet tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and metaanalysis. J Nucl Med. https://doi.org/10.2967/jnumed.119.233809

    Article  PubMed  Google Scholar 

  11. Zhao C, Zhang Y, Wang J (2014) A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A3718

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47(6):904–911

    CAS  PubMed  Google Scholar 

  13. Altieri R, Zenga F, Ducati A et al (2017) Tumor location and patient age predict biological signatures of high-grade gliomas. Neurosurg Rev. https://doi.org/10.1007/s10143-017-0899-8

    Article  PubMed  Google Scholar 

  14. Altieri R, Raimondo S, Tiddia C et al (2019) Glioma surgery: from preservation of motor skills to conservation of cognitive functions. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2019.08.091

    Article  PubMed  Google Scholar 

  15. Hervey-Jumper SL, Berger MS (2014) Role of surgical resection in low– and high-grade gliomas. Curr Treat Options Neurol. https://doi.org/10.1007/s11940-014-0284-7

    Article  PubMed  Google Scholar 

  16. Duffau H (2016) Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up. Acta Neurochir. https://doi.org/10.1007/s00701-015-2621-3

    Article  PubMed  Google Scholar 

  17. Sanai N, Berger MS (2018) Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol. https://doi.org/10.1038/nrclinonc.2017.171

    Article  PubMed  Google Scholar 

  18. Altieri R, Barbagallo D, Certo F et al (2021) Peritumoral microenvironment in high-grade gliomas: from flairectomy to microglia-glioma cross-talk. Brain Sci. https://doi.org/10.3390/brainsci11020200

    Article  PubMed  PubMed Central  Google Scholar 

  19. D’Alessio A, Proietti G, Sica G, Scicchitano BM (2019) Pathological and molecular features of glioblastoma and its peritumoral tissue. Cancers. https://doi.org/10.3390/cancers11040469

    Article  PubMed  PubMed Central  Google Scholar 

  20. Certo F, Altieri R, Maione M et al (2020) FLAIRectomy in supramarginal resection of glioblastoma correlates with clinical outcome and survival analysis: a prospective, single institution. Case Series Oper Neurosurg (Hagerstown). https://doi.org/10.1093/ons/opaa293

    Article  Google Scholar 

  21. Certo F, Stummer W, Farah JO et al (2019) Supramarginal resection of glioblastoma: 5-ALA fluorescence, combined intraoperative strategies and correlation with survival. J Neurosurg Sci. https://doi.org/10.23736/S0390-5616.19.04787-8

    Article  PubMed  Google Scholar 

  22. Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg. https://doi.org/10.3171/2015.5.JNS142087

    Article  PubMed  Google Scholar 

  23. Mampre D, Ehresman J, Pinilla-Monsalve G et al (2018) Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. Br J Neurosurg. https://doi.org/10.1080/02688697.2018.1498450

    Article  PubMed  Google Scholar 

  24. Müther M, Koch R, Weckesser M, Sporns P, Schwindt W, Stummer W (2019) 5-Aminolevulinic acid fluorescence-guided resection of 18f-fet-pet positive tumor beyond gadolinium enhancing tumor improves survival in glioblastoma. Neurosurgery. https://doi.org/10.1093/neuros/nyz199

    Article  PubMed  PubMed Central  Google Scholar 

  25. Pessina F, Navarria P, Cozzi L et al (2017) Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neuro-Oncol. https://doi.org/10.1007/s11060-017-2559-9

    Article  Google Scholar 

  26. Vivas-Buitrago T, Domingo RA, Tripathi S et al (2021) Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg. https://doi.org/10.3171/2020.10.JNS203366

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hirono S, Ozaki K, Kobayashi M et al (2021) Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study. Sci Rep. https://doi.org/10.1038/s41598-021-93986-z

    Article  PubMed  PubMed Central  Google Scholar 

  28. Altieri R, Zenga F, Fontanella MM et al (2015) Glioma surgery: technological advances to achieve a maximal safe resection. Surg Technol Int. 27(297):302

    Google Scholar 

  29. Barbagallo GMV, Certo F, Di Gregorio S et al (2021) Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome. Neurosurg Focus. https://doi.org/10.3171/2020.10

    Article  PubMed  Google Scholar 

  30. Della Pepa GM, Sabatino G, la Rocca G (2019) “Enhancing Vision” in high grade glioma surgery: a feasible integrated 5-ala + CEUS protocol to improve radicality. World Neurosurg. https://doi.org/10.1016/j.wneu.2019.06.127

    Article  PubMed  Google Scholar 

  31. Lau D, Hervey-Jumper SL, Chang S et al (2016) A prospective phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. J Neurosury. https://doi.org/10.3171/2015.5.JNS1577

    Article  Google Scholar 

  32. Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(06)70665-9

    Article  PubMed  Google Scholar 

  33. Stummer W, Stocker S, Wagner S et al (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurg 42(3):518–526

    CAS  Article  Google Scholar 

  34. Altieri R, Melcarne A, Junemann C et al (2019) Inferior fronto-occipital fascicle anatomy in brain tumor surgeries: from anatomy lab to surgical theater. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2019.07.039

    Article  PubMed  Google Scholar 

  35. Coello AF, Moritz-Gasser S, Martino J, Martinoni M, Matsuda R, Duffau H (2013) Awake Surgery: a shift from intraoperative single-language mapping toward more extensive cognitive mapping selection of intraoperative tasks for awake mapping based on relationships between tumor location and functional networks a review. J Neurosurg. https://doi.org/10.3171/2013.6.JNS122470

    Article  Google Scholar 

  36. Duffau H (2018) Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible? Neurosurg Rev. https://doi.org/10.1007/s10143-017-0918-9

    Article  PubMed  Google Scholar 

  37. Mandonnet E, Sarubbo S, Duffau H (2017) Proposal of an optimized strategy for intraoperative testing of speech and language during awake mapping. Neurosurg Rev. https://doi.org/10.1007/s10143-016-0723-x

    Article  PubMed  Google Scholar 

  38. Zigiotto L, Annicchiarico L, Corsini F et al (2020) Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery. J Neurooncol. https://doi.org/10.1007/s11060-020-03494-94006510

    Article  PubMed  Google Scholar 

  39. Hewitt SM, Lewis FA, Cao Y, Conrad RC, Cronin M, Danenberg KD, Goralski TJ, Langmore JP, Raja RG, Williams PM, Palma JF, Warrington JA (2008) Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. https://doi.org/10.5858/132.12.1929

    Article  PubMed  Google Scholar 

  40. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P (1988) Grading of astrocytomas . a simple and reproducible method. Cancer 62(10):2152–2165

    CAS  Article  PubMed  Google Scholar 

  41. Collins VP, Jones DT, Giannini C (2015) Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol. https://doi.org/10.1007/s00401-015-1410-7

    Article  PubMed  PubMed Central  Google Scholar 

  42. WHO Classification of Tumors Editorial Board (2021) Central nervous system tumours, 5th edn. International Agency for Research on Cancer, Lyon

    Google Scholar 

  43. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59(4):793–797

    CAS  PubMed  Google Scholar 

  44. Hench IB, Della Monica R, Chiariotti L, Bihl M, Tolnay M, Frank S, Hench J (2020) Fast routine assessment of MGMT promoter methylation. Neurooncol Adv. https://doi.org/10.1093/noajnl/vdaa170

    Article  PubMed  PubMed Central  Google Scholar 

  45. Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A (2015) Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. https://doi.org/10.1007/s00401-015-1432-1

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosa Della Monica.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethics approval

Not applicable

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Della Monica, R., Altieri, R., Ugga, L. et al. Workflow in the multidisciplinary management of glioma patients in everyday practice: how we do it. Clin Transl Imaging (2022). https://doi.org/10.1007/s40336-022-00505-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40336-022-00505-9

Keywords

  • Multidisciplinary approaches
  • GMB
  • Glioma
  • Diagnostic workflow